Kistler-Tiffany Companies’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-47
Closed -$6K 731
2021
Q1
$6K Hold
47
﹤0.01% 561
2020
Q4
$6K Hold
47
﹤0.01% 539
2020
Q3
$5K Hold
47
﹤0.01% 542
2020
Q2
$4K Hold
47
﹤0.01% 525
2020
Q1
$4K Hold
47
﹤0.01% 513
2019
Q4
$4K Hold
47
﹤0.01% 520
2019
Q3
$4K Hold
47
﹤0.01% 524
2019
Q2
$6K Sell
47
-168
-78% -$16.9K ﹤0.01% 487
2019
Q1
$19K Hold
215
0.01% 352
2018
Q4
$14K Hold
215
0.01% 360
2018
Q3
$17K Hold
215
0.01% 365
2018
Q2
$13K Hold
215
0.01% 388
2018
Q1
$9K Sell
215
-100
-32% -$4.88K ﹤0.01% 432
2017
Q4
$17K Hold
315
0.01% 391
2017
Q3
$15K Hold
315
0.01% 390
2017
Q2
$11K Hold
315
0.01% 396
2017
Q1
$7K Buy
+315
New +$6.24K ﹤0.01% 417

Other funds holding EXAS

Kistler-Tiffany Companies's EXAS Position: Q2 2021 in Review

Kistler-Tiffany Companies sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 47 shares — an estimated $6K sold.

Kistler-Tiffany Companies first reported a position in EXAS in Q1 2017 and held it in 17 quarters. The position peaked at $19K in Q1 2019. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Kistler-Tiffany Companies reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 47 Exact Sciences shares in Q2 2021, an estimated $6K.
  • Kistler-Tiffany Companies first reported a position in Exact Sciences in Q1 2017 and held it in 17 quarters.
  • Kistler-Tiffany Companies's Exact Sciences position peaked at $19K in Q1 2019.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2021, filed 4 Aug 2021.